Evidence map›Paper›PMID 35077956›Full record

Trial reportDrug and alcohol dependence2022

Abstinence-contingent wage supplements to promote drug abstinence and employment: Post-intervention outcomes.

Matthew D Novak, August F Holtyn, Forrest Toegel, Jeannie-Marie Leoutsakos, Kenneth Silverman

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Reward deprivation is associated with elevated alcohol demand in emerging adults.Journal of the experimental analysis of behavior · 2025
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew D NovakJohns Hopkins University School of Medicine, Baltimore, MD, United States.
August F HoltynJohns Hopkins University School of Medicine, Baltimore, MD, United States.
Forrest ToegelJohns Hopkins University School of Medicine, Baltimore, MD, United States.
Jeannie-Marie LeoutsakosJohns Hopkins University School of Medicine, Baltimore, MD, United States.
Kenneth SilvermanJohns Hopkins University School of Medicine, Baltimore, MD, United States. Electronic address: ksilverm@jhmi.edu.

Funding

HUMAN BEHAVIORAL PHARMACOLOGY OF SUBSTANCE ABUSET32DA007209 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Eric C. Strain, Elise M Weerts · 1985 to 2026
$12.9M
Abstinence-Contingent Wage Supplements for Long-Term Treatment of Drug AddictionR01DA037314 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SILVERMAN, KENNETH · 2015 to 2019
$3.4M
NIDA NIH HHS R01 DA037314NIDA NIH HHS T32 DA007209
6 · The paper itself

Abstract

backgroundSubstance use disorder, unemployment, and poverty are interrelated problems that have not been addressed adequately by existing interventions. This study evaluated post-intervention effects of abstinence-contingent wage supplements on drug abstinence and employment.

methodsUnemployed adults enrolled in opioid agonist treatment were randomly assigned to an abstinence-contingent wage supplement group (n = 44) or a usual care control group (n = 47). All participants could work with an employment specialist throughout a 12-month intervention period. Those in the abstinence-contingent wage supplement group earned stipends for working with the employment specialist and, after gaining employment, abstinence-contingent wage supplements for working in their community job but had to provide opiate- and cocaine-negative urine samples to maximize pay. To assess post-intervention effects of abstinence-contingent wage supplements and compare those effects to during-intervention effects, we analyzed urine samples and self-reports every 3 months during the 12-month intervention and the 12-month post-intervention period.

resultsDuring the intervention, abstinence-contingent wage supplement participants provided significantly more opiate- and cocaine-negative urine samples than usual care control participants; abstinence-contingent wage supplement participants were also significantly more likely to become employed and live out of poverty than usual care participants during intervention. During the post-intervention period, the abstinence-contingent wage supplement and usual care control groups had similar rates of drug abstinence, similar levels of employment, and similar proportions living out of poverty.

conclusionsLong-term delivery of abstinence-contingent wage supplements can promote drug abstinence and employment, but many patients relapse to drug use and cease employment when wage supplements are discontinued.

Indexed as

Opioid-Related DisordersAdultAnalgesics, OpioidEmploymentHumansReinforcement, PsychologySalaries and Fringe BenefitsAnalgesics, OpioidAbstinence reinforcementCocaineContingency managementEmploymentOpioidsTherapeutic workplace

Identifiers

PMID35077956
PMCPMC8885832

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.